SCHEMBL4075455

SCHEMBL4075455

CCOC(=O)Oc1cnc(Nc2ccc3[nH]ccc3n2)nc1NC1CCCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 11/20 0.40
MERTK Q12866 2/20 0.37
AXL P30530 1/20 0.37
TYRO3 Q06418 2/20 0.36
SELP P16109 1/20 0.36
NR2F2 P24468 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
ULK1 O75385 1/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
S1PR2 O95136 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
XBP1 P17861 1/20 0.36
RAB9A P51151 1/20 0.36
PPP1CA P62136 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4068769 0.86 NR2F2 (0.51) SYKMERTKAXLTYRO3NR2F2
SCHEMBL4073787 0.79 CDK4 (0.51) SYKCDK4CDK6CCND1CCND2
SCHEMBL4069730 0.78 CDK4 (0.57) SYKJAK3CDK4CDK6FLT3
SCHEMBL4066946 0.77 IGF1R (0.46) SYKULK1
SCHEMBL4068205 0.77 ULK1 (0.43) SYKMERTKTYRO3ULK1JAK2
SCHEMBL4071475 0.74 SYK (0.49) SYKCDK4CDK6CCND1CCND2
SCHEMBL4075543 0.70 SYK (0.53) SYKJAK3CDK4CDK6FLT3
SCHEMBL4066054 0.66 CDK4 (0.67) SYKNR2F2NPSR1KDM4EMAPT
SCHEMBL4071876 0.66 CDK4 (0.56) SYKNR2F2NPSR1KDM4EMAPT
Hydrochloric Acid SCHEMBL4066040 0.65 CDK4 (0.67) SYKNR2F2NPSR1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1590341-B1 2-AMINOPYRIDINE SUBSTITUTED HETEROCYCLES AS INHIBITORS OF CELLULAR PROLIFERATION WARNER LAMBERT CO (US) 2009-06-17 EP claimed